Literature DB >> 2805009

Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases.

K G Rice1, R J Linhardt.   

Abstract

The rapid preparation of multimilligram quantities of five heparin-derived oligosaccharides (1-5) is described. These oligosaccharides are the final products obtained from the action of heparin lyase (heparinase, E.C. 4.2.2.7) at its primary sites in the heparin polymer. Five oligosaccharides comprise from 75-85 wt% of commercial porcine mucosal heparins and are recovered in good yield and high purity. Four of these five oligosaccharides were further acted upon at much lower rates by prolonged treatment with heparin lyase or heparan monosulfate lyase (heparitinase, E.C. 4.2.2.8), revealing the subspecificities of these enzymes. These oligosaccharides were used as defined substrates for heparin lyase and heparan monosulfate lyase and their kinetic constants were obtained. Potential applications for these oligosaccharides include their use as defined substrates for purification of heparin monosulfate lyases, and for establishing the catalytic purity of enzyme preparations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805009     DOI: 10.1016/0008-6215(89)84127-8

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  14 in total

1.  Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.

Authors:  A J Rhomberg; S Ernst; R Sasisekharan; K Biemann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  NMR methods to monitor the enzymatic depolymerization of heparin.

Authors:  John F K Limtiaco; Szabolcs Beni; Christopher J Jones; Derek J Langeslay; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-04       Impact factor: 4.142

4.  Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.

Authors:  Yanlei Yu; Asher Williams; Xing Zhang; Li Fu; Ke Xia; Yongmei Xu; Fuming Zhang; Jian Liu; Mattheos Koffas; Robert J Linhardt
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

5.  Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations.

Authors:  A Lindblom; L A Fransson
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

6.  Negative ion fast-atom bombardment tandem mass spectrometry to determine sulfate and linkage position in glycosaminoglycan-derived disaccharides.

Authors:  D J Lamb; H M Wang; L M Mallis; R J Linhardt
Journal:  J Am Soc Mass Spectrom       Date:  1992-11       Impact factor: 3.109

7.  Cloning and expression of heparinase I gene from Flavobacterium heparinum.

Authors:  R Sasisekharan; M Bulmer; K W Moremen; C L Cooney; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Determination of the pKa of glucuronic acid and the carboxy groups of heparin by 13C-nuclear-magnetic-resonance spectroscopy.

Authors:  H M Wang; D Loganathan; R J Linhardt
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

9.  Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.

Authors:  Fiona H Blackhall; Catherine L R Merry; Malcolm Lyon; Gordon C Jayson; Judah Folkman; Kashi Javaherian; John T Gallagher
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

10.  Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1.

Authors:  Andrea F Moon; Suzanne C Edavettal; Joe M Krahn; Eva M Munoz; Masahiko Negishi; Robert J Linhardt; Jian Liu; Lars C Pedersen
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.